Muscle Biopsy: A Requirement for Precision Medicine in Adult-Onset Myopathy

Meng Ju Wu, Wei An Liao, Po Yu Lin, Yuan Ting Sun

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Muscle biopsy is a fundamental procedure to assist the final diagnosis of myopathy. With the recent advances in molecular diagnosis, serology tests, and mechanism-based classification in myopathy, the précised diagnosis for myopathy required the applications of multiple tools. This study intends to reappraise the benefit of muscle biopsy in adult-onset myopathy under the setting of an optimized muscle biopsy protocol and comprehensive serology tests. A one-group pretest-posttest study design was used. The pre-and post-biopsy diagnoses and treatments in 69 adult patients were compared. Muscle biopsy yielded 85.5% of definitive diagnoses, including changes in pre-biopsy diagnoses (40.6%) and narrowing down the suspicious myopathies (49.3%). The demographic data and clinical parameters between the group “with change” and “without change” after biopsy were not different. Among those with changes in diagnosis, 39.3% also had a corresponding shift in treatment, which benefits the patients significantly. Regarding the most common adult-onset myopathy, idiopathic inflammatory myopathy (IIM), 41% of patients with pre-biopsy diagnosis as IIM had changes in their IIM subtype diagnosis, and 53% was finally not IIM after muscle biopsy. Although there have been advances in molecular diagnosis recently, muscle biopsy still undoubtedly critically guided the diagnosis and treatment of adult-onset myopathy in the era of precision medicine.

Original languageEnglish
Article number1580
JournalJournal of Clinical Medicine
Issue number6
Publication statusPublished - 2022 Mar 1

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Muscle Biopsy: A Requirement for Precision Medicine in Adult-Onset Myopathy'. Together they form a unique fingerprint.

Cite this